{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-000733","form_type":"8-K","ticker":"PCSA","cik":"0001533743","company_name":"Processa Pharmaceuticals, Inc.","filed_at":"2026-01-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.355529+00:00","generated_at":"2026-05-16T11:20:57.769993+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Processa Pharmaceuticals regains compliance with Nasdaq $1.00 minimum bid price; delisting matter closed","bullets":["Received Nasdaq notification on January 6, 2026 confirming compliance with Listing Rule 5550(a)(2).","Company had previously been notified of bid price deficiency; now the deficiency is resolved.","Nasdaq Capital Market continued listing is no longer at risk from bid price requirement.","No other material changes; CEO George Ng signed the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-000733","json":"https://secwatch.observer/filing/0001493152-26-000733.json","markdown":"https://secwatch.observer/filing/0001493152-26-000733.md","text":"https://secwatch.observer/filing/0001493152-26-000733.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533743/000149315226000733/0001493152-26-000733-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533743/000149315226000733/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:20:57.769993+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}